We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+29.13%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$244M
AUM Growth
+$22M
Cap. Flow
-$10.5M
Cap. Flow %
-4.28%
Top 10 Hldgs %
43.92%
Holding
93
New
19
Increased
15
Reduced
7
Closed
46

Top Buys

1
WMGI
Wright Medical Group Inc
WMGI
+$10.8M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$9.94M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$9.37M
4
BLUE
bluebird bio
BLUE
+$9.25M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$8.83M

Top Sells

1
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$13.4M
2
AGN
Allergan plc
AGN
+$10.2M
3
GILD icon
Gilead Sciences
GILD
+$6.87M
4
CELG
Celgene Corp
CELG
+$6.49M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$5.71M

Sector Composition

1 Healthcare 89.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUVA
1
DELISTED
NuVasive, Inc.
NUVA
$12.4M 5.1%
230,000
+55,000
+31% +$2.8M
AMGN icon
2
Amgen
AMGN
$198B
$12.2M 4.99%
75,000
+25,000
+50% +$3.93M
WMGI
3
DELISTED
Wright Medical Group Inc
WMGI
$12.1M 4.95%
+500,000
New +$10.8M
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$11.8M 4.85%
230,000
+205,000
+820% +$9.94M
SAGE
5
DELISTED
Sage Therapeutics
SAGE
$11.7M 4.77%
200,000
+159,200
+390% +$7.89M
SGEN
6
DELISTED
Seagen Inc. Common Stock
SGEN
$10.1M 4.13%
+225,000
New +$9.37M
MNK
7
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$10.1M 4.13%
135,000
+15,000
+13% +$1.01M
PACB icon
8
Pacific Biosciences
PACB
$447M
$9.85M 4.03%
+750,000
New +$6.73M
ACAD icon
9
Acadia Pharmaceuticals
ACAD
$4.38B
$8.91M 3.65%
+250,000
New +$8.81M
IART icon
10
Integra LifeSciences
IART
$1.5B
$8.13M 3.33%
240,000
+90,000
+60% +$2.81M
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$7.9M 3.23%
+250,000
New +$8.83M
ZLTQ
12
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$7.85M 3.21%
275,000
+40,000
+17% +$1.26M
BLUE
13
DELISTED
bluebird bio
BLUE
$7.71M 3.16%
+9,264
New +$9.25M
BIIB icon
14
Biogen
BIIB
$30.4B
$7.66M 3.14%
+25,000
New +$7.18M
SPNC
15
DELISTED
Spectranetics Corp
SPNC
$6.55M 2.68%
435,000
+185,000
+74% +$2.44M
ACHN
16
DELISTED
Achillion Pharmaceuticals
ACHN
$6.47M 2.65%
600,000
+300,000
+100% +$2.73M
PRTA icon
17
Prothena Corp
PRTA
$453M
$6.13M 2.51%
+90,000
New +$5.43M
NSTG
18
DELISTED
NanoString Technologies, Inc.
NSTG
$5.88M 2.41%
400,000
-50,000
-11% -$736K
NVRO
19
DELISTED
NEVRO CORP.
NVRO
$5.74M 2.35%
+85,000
New +$4.55M
INCY icon
20
Incyte
INCY
$23.4B
$5.42M 2.22%
50,000
+25,000
+100% +$2.79M
DBVT
21
DBV Technologies
DBVT
$870M
$5.31M 2.18%
+8,000
New +$2.8M
VTAE
22
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$4.98M 2.04%
275,000
+25,000
+10% +$344K
ACOR
23
DELISTED
Acorda Therapeutics
ACOR
$4.28M 1.75%
833
– –
ALNY icon
24
Alnylam Pharmaceuticals
ALNY
$35.7B
$4.24M 1.73%
+45,000
New +$4.17M
FPRX
25
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$4.15M 1.7%
100,000
-400,000
-80% -$13.4M
1
2 3 4

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Ghost Tree Capital held 93 positions worth $244M, up 9.9% from $222M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Ghost Tree Capital withdrew a net $10.5M in Q4 2015, closing 46 positions and reducing 7 holdings. Its most notable exit was Allergan plc, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 83% a quarter earlier.

Against the trend, Ghost Tree Capital opened a new position in Wright Medical Group Inc worth $12.1M.

  • Ghost Tree Capital's largest Q4 2015 buy was Wright Medical Group Inc: 500,000 shares worth $12.1M.
  • Ghost Tree Capital added most to Portola Pharmaceuticals, Inc. in Q4 2015, an estimated $9.94M increase.
  • Ghost Tree Capital's biggest Q4 2015 reduction was Five Prime Therapeutics, Inc., cutting an estimated $13.4M.
  • Ghost Tree Capital fully exited Allergan plc in Q4 2015, selling an estimated $10.2M.
  • Ghost Tree Capital's ten largest holdings make up 44% of its $244M portfolio in Q4 2015.
  • Ghost Tree Capital opened 19 new positions and closed 46 in Q4 2015.
  • Ghost Tree Capital's portfolio value rose 9.9% quarter-over-quarter to $244M.

Based on Ghost Tree Capital's 13F filing for Q4 2015, filed 16 Feb 2016.